Combination Product Share of Drug Delivery Market to Approach $40 Billion; Greystone Associates Analyzes Impact in a Series of Surveys.AMHERST, N.H. -- The convergence of computerized design tools, engineered materials and particle technology are enabling the creation of drug-device combination products that were unattainable just a few short years ago. Recognizing the growing impact of combination products, the U.S. FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. established a new organizational entity in December of 2002 to coordinate the regulatory process for the rising number of applications comprised of two or more regulated components. The integration of drug and delivery device results in a synergistic merging in which therapeutic benefit is increased and outcomes are improved. The growth of combination products is having a significant effect on the way drugs and devices are developed. "Cooperation between device designers and drug developers is occurring much earlier in the drug development cycle, allowing device designs in many cases to be tailored to the bioavailability bioavailability /bio·avail·a·bil·i·ty/ (bi?o-ah-val?ah-bil´i-te) the degree to which a drug or other substance becomes available to the target tissue after administration. bi·o·a·vail·a·bil·i·ty n. targets and pharmacokinetic profiles of specific drug therapies", explains George Perros, Greystone Managing Director. The new devices are typically patient-friendly, easing compliance concerns, which have a non-negligible effect on drug formulations and delivery decisions, and are a significant factor in the prescribing decisions of most physicians. Combination drug delivery products are growing at an annual rate of fourteen percent across all technology segments, and will total $38 Billion in 2008. Growth will be led by inhalation inhalation /in·ha·la·tion/ (in?hah-la´shun) 1. the drawing of air or other substances into the lungs.inhala´tional 2. the drawing of an aerosolized drug into the lungs with the breath. 3. devices, including intranasal in·tra·na·sal adj. Within the nose. and pulmonary systemic therapeutics. Transdermal transdermal /trans·der·mal/ (-der´m'l) entering through the dermis, or skin, as in administration of a drug via ointment or patch. trans·der·mal adj. Through or by way of the skin. delivery - in particular drug patches capable of delivering two or more drugs, and patches based on microneedle technology - will also contribute significantly. More information is available at www.greystoneassociates.org . Information on our downloadable 2004 Catalog of Drug Delivery Publications is available at http://www.greystoneassociates.org/2004Catalog.htm About Greystone Greystone Associates is a medical and healthcare technology consulting firm Noun 1. consulting firm - a firm of experts providing professional advice to an organization for a fee consulting company business firm, firm, house - the members of a business organization that owns or operates one or more establishments; "he worked for a providing services in strategic planning Strategic planning is an organization's process of defining its strategy, or direction, and making decisions on allocating its resources to pursue this strategy, including its capital and people. , venture development, product commercialization, and technology and market assessment. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion